Paydirt
BP
Insider

Brian T. Powl

Chief Commercial Officer

Brian T. Powl (Chief Commercial Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Kura Oncology, Inc. (KURA). The largest single filing was $110K of KURA (10,000 sh × $11.00, as filed), executed May 21.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$110K
shares × price, as filed
Last traded
May 21
Filed May 22

Median ADV $20.0M across their filed names

Open performance→
Volume by month
$110K$55K$0Oct 2024Apr 2025Oct 2025Apr 2026May 2026 · sells $110K
Buys $0 Sells $110K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names
KURA Kura Oncology, Inc. KURA · 0 buys · 1 sell 1 filing
Recent filings
KURASALE Kura Oncology, Inc. View filing → $110K
10,000 sh × $11.00
Exec May 21
Filed May 22 · 5:30 PM ET